Similarly, in HepG2 cells, TF1 demonstrated the strongest hepatoprotective effect, reducing ALT (p < 0.001, Figure 2D ) and AST (p < 0.001, Figure 2E ) levels most significantly, followed by TF2A and TF2B, whereas TFDG showed a weaker effect that did not reach statistical significance.
← all excerpts
Theaflavins counteract free fatty acid-driven oxidative-inflammatory injury in endothelial cells through Nrf2-NF-κB axis.
1
—
—